Skip to main content
. 2021 Jan 4;12(1):8. doi: 10.1038/s41419-020-03308-w

Fig. 2. Verteporfin-NP more effectively inhibits the migration of TNBC cells and fully suppresses YAP target genes upregulated by paclitaxel-NP and/or combretastatin-NP.

Fig. 2

A TNBC MDA-MB-231 cells were grown to confluence, treated with mitomycin to inhibit cell proliferation, and then scratched and quantified for migration after incubation with E (empty-NP), 5 nM P (paclitaxel-NP), 250 nM V (verteporfin-NP), 5 nM C (combretastatin-NP), or different combinations for 48 hrs. B Representative images of A. C, D RT-qPCR analysis of changes of YAP target gene in MDA-MB-231 cells after 24 -hr of treatment with E (empty-NP), 25 nM P (paclitaxel-NP), 1.25 µM V (verteporfin-NP), 25 nM C (combretastatin-NP), and different combinations. Data represent means ± SEM, *P < 0.05, **P < 0.01, ****P < 0.0001.